Gala vs MyStart Health: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MyStart Health beats Gala overall, scoring 7.7/10 vs 7/10. Gala is more affordable at $149/mo vs $299/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose MyStart Health for users who value a money-back weight-loss guarantee and price.
A side-by-side comparison of Gala and MyStart Health covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaMyStart Health
#21 of 42GLP-1 provider offering a unique money-back guarantee and price-lock protection for long-term cost certainty.
Visit MyStart Health| Feature | Gala | MyStart Health |
|---|---|---|
| Our Score | 7/10 | 7.7/10 |
| Starting Price | $149/mo | $299/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Users who value a money-back weight-loss guarantee and price-lock protection |
| Ranking | #40 | #21 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
MyStart Health
Pros
- +Price Lock Guarantee ensures your monthly rate never increases even as your GLP-1 dose escalates — a genuine differentiator
- +Access to 600+ board-certified doctors with unlimited clinician messaging at no additional cost
- +Competitive pricing at $149-$179/mo for compounded semaglutide with free shipping included
- +HSA/FSA eligible — can use pre-tax health savings to pay for treatment
Cons
- −Cash-pay only — no insurance accepted, which limits options for patients with GLP-1 coverage
- −Only available in select states — not all 50, and the exact state list isn't published
- −Compounded medications only — no brand-name GLP-1 options available
Our Verdict
MyStart Health edges out Gala with a score of 7.7/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to MyStart Health's $299/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose MyStart Health if you want: users who value a money-back weight-loss guarantee and price-lock protection.